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Abstract 
Crocin, a component of saffron, showed hypotensive which is perhaps due to vascular smooth muscle 
relaxant effect. The relaxant effects of saffron on tracheal smooth muscle also could be due to its 
constituent, crocin. In the present study, the relaxant effects of crocin and its possible mechanisms on rat 
tracheal smooth muscle were investigated. The relaxant effects of three cumulative concentrations of crocin 
(30, 60, and 120 μM) or theophylline (0.2, 0.4, 0.6 mM) as positive control were examined on pre-
contracted tracheal smooth muscle by methacholine or KCl in non-incubated or incubated conditions with 
different agents including atropine, chlorpheniramine, indomethacin, diltiazem, glibenclamide, and 
propranolol. In non-incubated tracheal smooth muscle, crocin showed significant relaxant effects on KCl 
induced muscle contraction (p < 0.001 for two higher concentrations). However, crocin did not show 
relaxant effect on methacholine induced tissue contraction. In incubated tissues with chlorpheniramine, 
indomethacin, diltiazem and propranolol, there were no significant differences in the relaxant effects of 
crocin between non-incubated and incubated tissues. However, the relaxant effects of crocin obtained in 
incubated tissues with atropine and glibenclamide were significant lower than non-incubated tracheal 
smooth muscle (p < 0.05 to p < 0.001). EC50 obtained in incubated tissue with propranolol was significantly 
increased. Theophylline showed significant relaxant effect on both KCl and methacholine induced tissue 
contraction (p < 0.01 to p < 0.001). A relatively potent relaxant effect of crocin on tracheal smooth muscle, 
lower than that of theophylline was shown. Muscarinic receptor blocking, potassium channels opening and 
ß2-adrenoreceptors stimulation were also suggested as possible mechanisms of this effect. 
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Introduction 
The genus Crocus includes roughly 88 species among which Crocus sativus L. (C. sativus) or saffron, 
is the most important species which studied widely for its various pharmacological properties (1). Saffron, 
the dried stigma of the plant C. sativus, has three major characteristic components (a) crocin, the principle 
coloring pigment (mono and diglycosyl esters of a polyene dicarboxylic acid, named crocetin), (b) the 
glycoside picrocrocin which is a precursor of safranal and responsible for its distinctly bitter ﬂavor and (c) 
safranal, a monoterpen aldehyde which is the deglycosylated form of picrocrocin and the major organoleptic 
principle of the stigmas (1). 
The crocins (C44H64O24) are a group of hydrophilic carotenoides that are either mono- or di-glycosyl 
polyene esters of crocetin in which D-glucose and/or D-gentiobiose occur as carbohydrate residues. 
At present, saffron is almost exclusively used as a natural ﬂavoring in the food industry. Recent 
studies have boosted interest in its medicinal properties as antioxidants, antitumorigenic, memory 
enhancers, antidepressants and anxiolytics, aphrodisiac, genoprotectives, antitussives, cardioprotectives, 
and neuroprotectives (2-29). The relaxant effect of the plant extract and safranal on tracheal smooth muscle 
(30, 31) and their effects on lung inflammation (32-35), pathological changes (32) and immunoregulation 
(34) in animal model of asthma were also shown. 
The effects of saffron petals extracts on blood pressure, hypotensive effect of aqueous extract of C. 
sativus and its constituents, safranal and crocin, were shown (36). Administration of 50 mg/100 g of 
aqueous extract of saffron changed the blood pressure from 133.5 ± 3.9 to 117 ± 2.1 mmHg (36) and the 
effect of chronic administration of saffron stigma aqueous extract on systolic blood pressure was shown 
(37). In addition, the effect of saffron on uterine contraction was also investigated (38). For C. sativus and 
its constituent safranal, a stimulatory effect on ß2- adrenoceptors (31), an inhibitory effect on histamine H1 
receptors (39) and a functional antagonistic effect on muscarinic receptors were demonstrated (40). 
Abundant research has been conducted concerning the biological and pharmacological properties of 
two saffron ingredients, safranal (41) and crocin. It has been shown that crocin exhibits pharmacological 
effects on many organs including the nervous system, gastrointestinal, cardiovascular, genital, endocrine, 
immune systems, etc (42). Some of these pharmacological effects including learning and memory, 
depression and anxiety, cerebral ischemia via inhibition of reperfusion-induced oxidative/nitrative injury, 
atherosclerosis, hyperlipidemia and hypertension, myocardial injury, sexual function, carcinogenesis via 
delayed the formation of papillomas and strong cytotoxic effect, antioxidant activity, inflammation and 
genotoxicity (42). Hosseinzadeh and coworkers showed that crocin at pharmacological doses did not exhibit 
marked damages to all the major organs of the body (43). Crocin was shown Low toxicity in rats even in 
high experimental dosage (44). 
The effects of chronic and subchronic crocin treatment in hypertension (45, 46) were demonstrated. 
Five weeks administration of three doses of crocin (50, 100 and 200 mg/kg/day) could reduce the mean 
systolic blood pressure (MSBP) in DOCA salt treated rats in a dose dependent manner. Crocin did not 
decrease the MSBP in normotensive rats (46). Although the last study did not show antihypertensive effect, 
this effect of crocin is perhaps due to its relaxant effect on vascular smooth muscle. The protective effect 
of crocin on reperfusion induced cardiac arrhythmias (47) as well as the lowering effect on heart rate and 
contractility was also documented (48). The results suggested that crocin is partially capable of suppressing 
reperfusion-induced arrhythmias (47).   
Therefore, in the present study, the relaxant effect of crocin on rat tracheal smooth muscle and the 
possible underlying mechanism(s) responsible for this effect were examined. 
 
Experimental 
Animals 
Sixty-four male Wistar rats weighing approximately 200–250 g (Animal house, School of Medicine, 
Mashhad University of Medical Sciences, Iran) were housed in Plexiglas cages in a temperature-controlled 
environment (20 ± 2 °C) on a 12-h light-dark schedule with standard diet and tap drinking water available 
ad libitum. The study was approved by the ethics committee of Mashhad University of Medical Sciences 
(No. 931653) for Animal Experiments. 
 
Tissue preparation 
For obtaining the trachea, the rats were sacrificed by blow on the neck and the chest was opened and 
excess of connective tissue and fat were dissected out. The trachea was cut into rings of 3 to 4 mm in width; 
each ring contains about four cartilages for the formation of tracheal ring. Each tracheal ring was hung 
between two Nichrome hooks inserted into the lumen, and placed in a 10 mL organ bath. The bath 
containing Krebs-Henseliet solution (KHS) composed of (mM): NaCl 120, KCl 4.72, KH2PO4 1.2, 
MgSO4·7H2O 0.5, CaCl2·2H2O 2.5, NaHCO3 25 and Dextrose 11 which was maintained at 37 ± 0.5 °C and 
bubbled constantly with 5% CO2-95% O2. Tissue was suspended under isotonic tension of 1 g and allowed 
to equilibrate for at least 1 h while it was washed with KHS solution every 15 min. In all experiments 
contraction responses were measured using an isotonic transducer (MLT0202, AD Instruments, Australia) 
which was connected to a power lab system (Power Lab 8/30, ML870, AD Instruments, Australia). The 
study duration was 12 months. 
 
Protocol 
Cumulative concentrations of crocin (30, 60, and 120 μM), purchased from Sigma Chemical Co 
(crocin-1, alpha-crocin, Crocetin di-β-D-gentiobiose ester, C44H64O24, molecular weight 976.972 g/mol, St 
Louis, MO, USA), or theophylline (0.2, 0.4, and 0.6 mM) as positive control (Sigma Chemical Co, St Louis, 
MO, USA) were added on pre-contracted tracheal smooth muscle in 5 min intervals to produce 
concentration response curves. As negative control, the effect of 1 mL saline on pre-contracted tracheal 
smooth muscle was also evaluated in each experiment. With regard to molecular weight of crocin (976.96 
g/mol), the used studied concentrations of crocin are nearly 30, 60, and 120 μM. The percentage of 
relaxation due to each concentration of crocin or theophylline in proportion to the maximum contraction 
due to contractile agent (methacholine or KCl) was plotted against crocin or theophylline concentration to 
produce concentration response curve in each experiment. The effective concentration of crocin causing 
50% of maximum response (EC50) was also calculated as previously described (41). 
 
Study groups 
To examine the relaxant effect of crocin, tracheal smooth muscle was contracted by contractile agent 
for 5 min on non-incubated or incubated tissues with different substance for 10 min as follows: 
A- Tracheal smooth muscle was contracted by 60 mM KCl (Merk, Germeny) in the following 
groups; 
I) Non-incubated tissues (n = 8) 
II) Incubated tissues with: 
a. One μM atropine (Sigma Chemical Ltd UK), (n = 7) 
b. One μM chlorpheniramine (Sigma Chemical Ltd UK), (n = 7) 
c. One μM indomethacin (Sigma Chemical Ltd UK), (n = 6) 
d. Five μM diltiazem (Sigma Chemical Ltd UK), (n = 5) 
e. One μM glibenclamide (Sigma Chemical Ltd UK), (n = 5) 
f. One μM propranolol (Sigma Chemical Ltd UK), (n = 6) 
B- Non-incubated tracheal smooth muscle contracted by 10 μM methacholine (Sigma Chemical Ltd. 
UK), (n = 8) 
Each experimental group was done in random order in one tissues. Occasionally, few experimental 
groups were performed in one tissue with one hour resting period between two experiments while washing 
tissues with KHS solution every 15 min. The effect of theophylline as positive control was only examined 
on non-incubated tissues (n = 6 for each group).  
 
 
 
Data analysis 
Data are presented as mean ± SEM. The results were analyzed using one-way analysis of variance 
(ANOVA) followed by Tukey’s Multiple comparison test. Statistically significant was considered as p < 
0.05. 
 
Results 
The relaxant effect of crocin in non-incubated tracheal smooth muscle contracted with KCl 
 
The two higher concentrations of crocin showed significant and concentration-dependent relaxant 
effects in non-incubated tracheal smooth muscle contracted by KCl (p < 0.001 for both cases), (Figure 1). 
 
 
Figure 1. Concentration-response relaxant effect (mean ± SEM) of crocin (n = 8) and theophylline (n = 6) 
on KCl (60 mM) induced contraction of tracheal smooth muscle in non-incubated tissues. 1, 2 and 3 in X 
axis represent three concentration of crocin (30, 60, and 120 μM) and theophylline (0.2, 0.4, and 0.6 mM). 
***p < 0.001 compared to saline (NS). ++p < 0.01, +++p < 0.001 compared to the effect of theophylline. 
Statistical comparisons were performed using ANOVA with Tukey Kramer post-test. 
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 The relaxant effect of crocin in incubated tracheal smooth muscle contracted with KCl 
Crocin showed significant and concentration-dependent relaxant effect in incubated tracheal smooth 
muscle with chlorpheniramine, indomethacin (p < 0.05 to p < 0.001 for both cases), diltiazem (p < 0.05 to 
p < 0.01), and propranolol (p < 0.05), (Figure 2). There was no significant difference in the relaxant effects 
of crocin between non-incubated and incubated tissue with chlorpheniramine, indomethacin, diltiazem, and 
propranolol (Figure 2). 
 
 Figure 2. Concentration-response relaxant effect (mean ± SEM) of crocin on KCl (60 mM) induced 
contraction of tracheal smooth muscle in non-incubated (n = 8) and incubated tissues with (a) atropine (1 
μM, n = 7), (b) glibenclamide (1 μM, n = 5). *p < 0.05, ***p < 0.001, compared to saline (as indicated by 
zero in X axis of the figure). +p < 0.05, ++p < 0.01 +++p < 0.001, compared to non-incubated tissues. 
Statistical comparisons were performed using ANOVA with Tukey Kramer post-test. 
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In incubated tissues with atropine and glibenclamide, crocin showed significant and concentration-
dependent relaxant effects (p < 0.05 to p < 0.001 and p < 0.05 to p < 0.01, respectively), (Figure 3). The 
relaxant effects of two higher concentrations of crocin were significantly lower in incubated tissue with 
atropine compared to non-incubated tracheal smooth muscle (p < 0.01 to p < 0.001), (Figure 3a). The 
relaxant effects of medium concentrations of crocin were significantly lower in incubated tissue with 
glibenclamide compared to non-incubated tracheal smooth muscle (p < 0.05), (Figure 3b). 
 
 
Figure 3. Concentration-response relaxant effect (mean ± SEM) of crocin on KCl (60 mM) induced 
contraction of tracheal smooth muscle in non-incubated (n = 8) and incubated tissues with (a) 
chlorpheniramine (1 μM, n = 7), (b) indomethacin (1 μM, n = 6), (c) diltiazem (5 μM, n = 5), and (d) 
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propranolol (1 μM, n = 6). *p < 0.05, **p < 0.01, ***p < 0.001 compared to saline (as indicated by zero in X 
axis of the figure). Statistical comparisons were performed using ANOVA with Tukey Kramer post-test. 
 
There was no significant difference in EC50 values of crocin between non-incubated (51.62 ± 4.01) 
and incubated tissue with chlorpheniramine (51.57 ± 2.67), indomethacin (53.5 ± 10.24), and diltiazem 
(33.4 ± 6.8). However, the results showed significant difference in EC50 values of crocin, between non-
incubated and incubated tissue with atropine (65.28 ± 4.5), glibenclamide (65 ± 4.85), and propranolol 
(70.33 ± 5.01), (Figure 4). 
 
 
Figure 4. EC50 values of crocin induce relaxation obtained on contracted tracheal smooth muscles of rat 
with 60 mM KCl in non-incubated (n = 8) and incubated tissues with atropine (n = 7), chlorpheniramine (n 
= 7), indomethacin (n = 6), diltiazem (n = 5), glibenclamide (n = 5) and propranolol (n = 6). *p < 0.05, **p 
< 0.01 compared to non-incubated tissues. Statistical comparisons were performed using ANOVA with 
Tukey Kramer post-test. 
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 The relaxant effect of low concentrations of crocin in diltiazem incubated tracheal smooth muscle 
was significantly higher than those of incubated tissues with atropine (p < 0.001), chlorpheniramine (p < 
0.001), indomethacin (p < 0.05), glibenclamide (p < 0.001) and propranolol (p < 0.001) in KCl induced 
muscle contraction. Additionally, the relaxant effect of medium concentrations of crocin in diltiazem 
incubated tissues was also significantly higher than those of incubated tracheal smooth muscle with atropine 
(p < 0.01) and glibenclamide (p < 0.05), (Table 1). The relaxant effects of medium and high concentrations 
of crocin in incubated tissues with atropine were significantly higher than those of incubated smooth 
muscles with chlorpheniramine and indomethacin (p < 0.05 to p < 0.01), (Table 1). 
 
Table 1. Comparison of the relaxant effects of three concentrations of crocin (percentage change in 
proportion to the maximum contraction) in different incubated tracheal smooth muscles contracted by 60 
mM KCl. 
 
Concentration (μM) Incubating substance 
120 60 30 
28.8 ± 3.79 13.03 ± 3.28** 7.24 ± 2.21*** Atropine 
50.55 ± 2.68# 29.78 ± 2.2## 11.05 ± 3.1*** Chlorpheniramine 
59.61 ± 10.55## 27.01 ± 4.04# 14.69 ± 3.07 * + Indomethacin 
60.21 ± 16.42 43.65 ± 12.67 30.08 ± 5.16 Diltiazem  
39.56 ± 15.71 14.3 ± 3.26* 9.32 ± 1.76*** Glibenclamide  
67.44 ± 25.71 19.81 ± 6.51 3.37 ± 0.82*** Propranolol 
Data were presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 compared to incubated tissues with 
diltiazem. +p < 0.05 compared to incubated tissues propranolol. #p < 0.05, ##p < 0.01 compared to incubated 
tissues with atropine. 
 
 
The relaxant effect of crocin in non-incubated tracheal smooth muscle contracted by methacholine 
In non-incubated tracheal smooth muscle contracted by methacholine, crocin did not show any 
relaxant effect (Figure 5). The relaxant effects of various concentrations of crocin on tracheal smooth 
muscle contracted by methacholine were significantly lower than those obtained in KCl induced contraction 
(p < 0.01 to p < 0.001), (Figure 6). 
 
 
Figure 5. Concentration-response relaxant effect (mean ± SEM) of crocin (n = 8) and theophylline (n = 6) 
on methacholine (10 μM) induced contraction of tracheal smooth muscle in non-incubated tissues. 1, 2 and 
3 in X axis represent three concentration of crocin (30, 60, and 120 μM) and theophylline (0.2, 0.4, and 0.6 
mM). ***p < 0.001 compared to saline (NS). +++p < 0.01 compared to the effect of theophylline. Statistical 
comparisons were performed using ANOVA with Tukey Kramer post-test.  
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 Figure 6. Concentration-response relaxant effect (mean ± SEM) of crocin on methacholine (10 μM) and 
KCl (60 mM) induced contraction of non-incubated tracheal smooth muscle (n = 8). ***p < 0.001 compared 
to saline (as indicated by zero in X axis of the figure). ++p < 0.01, +++p < 0.001, compared to the relaxant 
effect on methacholine induced muscle contraction. Statistical comparison of the effect of each 
concentration between two groups was performed using unpaired t-test. 
 
 
 
Comparison of the relaxant effect of crocin and theophylline 
The relaxant effect of two lower concentrations of crocin was significantly lower than that of 
theophylline in KCl induced contraction of non-incubated tracheal smooth muscle (p < 0.01 to p < 0.001), 
(Figure 1). The relaxant effects of all concentrations of theophylline were significantly higher than those of 
crocin in tracheal smooth muscle contracted by methacholine (p < 0.001 for all concentrations), (Figure 5). 
 
 
++
***
+++
***
+++
-60
-40
-20
0
20
40
60
80
100
0 30 60 120
T
ra
ch
ea
l 
re
la
x
ti
o
n
 r
es
p
o
n
se
 i
n
 p
ro
p
o
rt
io
n
 
to
 m
a
x
im
u
m
e 
co
n
tr
a
ct
io
n
(%
)
Concentration (μM)
KCl Incubated Contraction
Methacholine Induced Contraction
Discussion 
In this study, the relaxant effect of crocin in pre-contracted tracheal smooth muscle by KCl and 
methacholine was examined. In non-incubated tracheal smooth muscle contracted by KCl, crocin showed 
significant and concentration dependent relaxant effect. The relaxant effect of two higher concentrations of 
crocin was significantly lower than that of theophylline. These results indicated a relatively potent relaxant 
effect of crocin. 
For C. sativus and its constituent safranal, a stimulatory effect on ß2- adrenoceptors (31), an inhibitory 
effect on histamine H1 receptors (47) and a functional antagonistic effect on muscarinic receptors were 
demonstrated (48). To evaluate these possible mechanisms, as well as other possible mechanisms for the 
relaxant effect of crocin, its effect was examined on tracheal smooth muscle incubated with atropine, 
chlorpheniramine, indomethacin, diltiazem, glibenclamide, and propranolol. 
In incubated tracheal smooth muscle with atropine and contracted with KCl, the relaxant effect of 
crocin examined to assess the contribution of muscarinic receptor inhibitory effect on the relaxant property 
of crocin. The results showed significant lower relaxant effects of two higher concentrations of crocin in 
incubated tissues with atropine compared to non-incubated tracheal smooth muscle. These results indicated 
the inhibitory effect of crocin on muscarinic receptors which could be contributed in its relaxant effect on 
tracheal smooth muscle. In fact, the relaxant effect of muscarinic receptor blocking drugs on tracheal 
smooth muscle was previously documented (49). The study of Nemati et al. (2010) demonstrated the 
functional antagonistic effect of C. sativus and safranal on muscarinic receptors on tracheal muscle of 
guinea pigs. Both the extract and safranal shifted methacholine concentration-response curve to the right. 
However, the shift was not parallel and the maximum response to methacholine in the presence of extract 
and safranal was not obtained. These results indicated a functional antagonistic effect of the plant and 
safranal on muscarinic receptors (48). These two studies nearly supported the results of the present study 
regarding the inhibitory effect of crocin on muscarinic receptors.   
To examine the effect of crocin on histamine (H1) receptor and the role of this mechanism on the 
relaxant effect of crocin on tracheal smooth muscle, the relaxant effect of crocin was examined on tracheal 
smooth muscle incubated with chlorpheniramine and contracted with KCl. The findings of this group 
showed non-significant difference in the relaxant effect of crocin in incubated tracheal smooth muscle with 
the results of non-incubated tissue. These results indicate the absence of the inhibitory effect of crocin on 
histamine (H1) receptor and therefore, this mechanism is not responsible for the relaxant effect of crocin 
on tracheal smooth muscle. However, the relaxant effect of histamine (H1) receptor blocking drugs on 
tracheal smooth muscle was shown previously (50). The inhibitory effect of extracts of C. sativus on 
histamine (H1) was also shown previously. The effect of three concentrations of aqueous-ethanolic extracts 
of C. sativus (0.025%, 0.05% and 0.1%) on histamine (H1) receptors was evaluated in guinea pig tracheal 
smooth muscles previously. Concentration-response curve of histamine was obtained in the presence of 
saline, saffron extract, and chlorpheniramine. The extract caused parallel rightward shift in histamine 
concentration-response curve similar to the effect of chlorpheniramine and the maximum response to 
histamine was obtained in the presence of the extract. These results showed an inhibitory effect of C. sativus 
(competitive antagonistic effect) on histamine H1 receptors which could be related to the relaxant effect of 
the plant on tracheal smooth muscle (47). The reason of the differences between the effect of the extract of 
saffron, safranal and corcin on histamine (H1) receptors is uncertain to us and should be examined in further 
studies.  
To evaluate the involvement of prostacyclin mechanism in crocin induced tracheal smooth muscle 
relaxation, its effect was also examined in incubated tissues with indomethacin. Prostacyclin (PGI2) is an 
epithelium releasing factor produced by epithelial cyclooxygenase. Prostacyclin leads to elevation of cyclic 
AMP and finally reduces the availability of calcium and induces smooth muscle cell relaxation (51). The 
anti-inflammatory effect of crocin was also seen previously (52). Non-significant difference in the relaxant 
effect of crocin between non-incubated and incubated tissues with indomethacin showed that COX 
inhibitory effect of crocin does not affect its tracheal smooth muscle relaxation. 
In incubated tracheal smooth muscle with diltiazem also the relaxant effect of crocin was studied to 
assess the role of calcium channel-blocking property in the relaxant effect of crocin. No significant 
difference was seen between the relaxant effects of crocin in non-incubated and incubated tissue with 
diltiazem. Therefore, calcium channel-blocking is not contributed in the relaxant effect of crocin on tracheal 
smooth muscle. Crocin could inhibit Ca2+ influx and release of intracellular Ca2+ stores in the endoplasmic 
reticulum in bovine aortic smooth muscle cells (53). It was also shown that reduction of intracellular Ca2+ 
release may contribute to relaxation of the corpus cavernosum, leading to erection (54). The effect of C. 
sativus on Ca2+ influx in isolated rat aortas was investigated using 45Ca as a radioactive tracer, and their 
calcium antagonistic effects were evaluated. Ca2+ uptake in isolated rat aorta rings in normal physiological 
status was not markedly altered by these drugs, whereas Ca2+ influxe induced by norepinephrine 1.2 
µmol/L and KCl 100 mmol/L were significantly inhibited by C. sativus in a concentration-dependent 
manner. The results showed that Ca2+ influx through receptor-operated Ca2+ channels and potential-
dependent Ca2+ channels can be blocked by the plant (55). It has been reported that crocetin decreased 
protein kinase C (PKC) activity in the membrane fraction, which led to reduced blood pressure by inhibition 
of proliferation in vascular smooth muscle cells (56). However, the results of the present study did not 
reveale a calcium channel inhibitory effect of crocin. The possible reason of the differences between the 
results of the and previously studies should be examined in further studies. 
In incubated tracheal smooth muscle with glibenclamide as well as the relaxant effect of crocin was 
studied to assess the role of potassium channel-blocking property in its relaxant effect. The relaxant effects 
of medium concentrations of crocin were significantly lower in incubated tissue with glibenclamide 
compared to non-incubated tracheal smooth muscle. These results indicated the inhibitory effect of crocin 
on potassium channels which could be contributed in its relaxant effect on tracheal smooth muscle. 
The most possible mechanism for the relaxant effect of agents on tracheal smooth muscle is their 
stimulatory effect on ß2-adrenergic receptors. To evaluate the effect of crocin on ß2- adrenoceptors and the 
role of this mechanism, the relaxant effect of crocin was examined on tracheal smooth muscle incubated 
with propranolol and contracted with KCl. The relaxant effect of ß2- adrenoceptors stimulatory drugs on 
tracheal smooth muscle was shown previously (50). There was no significant difference in the relaxant 
effects of crocin between non-incubated and incubated tissue with propranolol. These results indicate the 
absence of the stimulatory effect of crocin on ß2- adrenoceptors and therefore, this mechanism is not 
responsible for the relaxant effect of crocin on tracheal smooth muscle. However, the ß2-adrenergic 
stimulatory effect of the plant and safranal was tested by performing cumulative concentration-response 
curves of isoprenaline-induced relaxation of pre-contracted isolated guinea pig tracheal smooth muscle. 
The results showed leftward shifts in isoprenaline curves obtained in the presence of saffron extract and 
safranal compared to that of saline while propranolol caused rightward shift in isoprenaline response curve. 
The results indicated a relatively potent stimulatory effect of C. sativus extract and its constituent safranal 
on ß2-adrenoreceptors (31). Therefore, the results suggested that the major mechanism responsible for the 
relaxant effect of the plant and safranal is their stimulatory effect on ß2-adrenoreceptors. This discrepancy 
also should needs further investigations.   
Higher EC50 values of crocin induced relaxant effect and lower relaxant effect of crocin obtained in 
incubated tissues with atropine and glibenclamide compared to non-incubated tissues also support the 
contribution of muscarinic receptor inhibitory and potassium channel-blocking properties of crocin in its 
relaxant effect on tracheal smooth muscle. The results also showed significant difference in EC50 values of 
crocin between non-incubated and incubated tissue with propranolol. Although, there was no significant 
difference in the relaxant effects of crocin between non-incubated and incubated tissue with propranolol, 
the higher EC50 value obtained in incubated tissues with propranolol may indicate a component of 
stimulatory effect of crocine on ß2-adrenoreceptors. 
On methacholine induced contraction of tracheal smooth muscle, crocin did not show any significant 
relaxant effect. The absence of the relaxant effect of crocin in the methacholine induced contraction of 
smooth muscle almost excluded the role of the muscarinic receptor inhibitory effect of crocin on its smooth 
muscle relaxant property. The discrepancy between the results of crocin on methacholine induced muscle 
contraction and incubated tissue with atropine and contracted with KCl is unclear to us and should be 
evaluated in further studies. 
The absence of the relaxant effect of crocin on methacholine induced muscle contraction and 
relatively potent relaxant on KCl induced muscle contraction may indicate that the main mechanism of the 
relaxant effect of crocin is its inhibitory effect on calcium channels and/or opening effect on potassium 
channels. In fact, the relaxant effect of potassium channels opening drugs (57-59) and calcium channel 
blocking drugs (60) on tracheal smooth muscle were shown previously. 
Previous studies showed the relaxant effect of crocin in various types of smooth muscle which support 
the findings of the present study. Imenshahidi et al. compared the hypotensive effect of saffron aqueous 
extract and its two active ingredients in rats. Based on their results, aqueous extract of saffron stigma, 
safranal and crocin decreased mean arterial blood pressure in a dose-dependent manner. The hypotensive 
effect of the extract is perhaps due to its relaxant effect on vascular smooth muscle. The results also 
suggested that safranal, the major constituent of the plant, contributes to the hypotensive activity (25). The 
effect of crocin (50 mg/kg) on the reduction of systolic blood pressure (SBP) and the increased heart rate 
(HR) induced by diazinon (DZN) in rats, was shown which could be due to the relaxant effect of crocin on 
vascular muscle cells (38). It was also shown that crocetin (15, 30 mg/kg) dose-dependently improved 
endothelium-dependent relaxation (EDR) in response to acetylcholine (Ach) in high cholesterol diet 
(HCD)-fed rabbits. In addition, in bovine aortic endothelial cells (BAECs), oxidized LDL (oxLDL) 
treatment decreased nitric oxide production and down-regulated the activity and mRNA expression of 
endothelial nitric oxide synthase and these effects were inhibited by crocetin (0.1, 1, 10 mM) in a dose-
dependent manner (61). The effect of C. sativus petals extracts on isolated guinea-pig ileum induced by 
electrical field stimulation (EFS) was studied. In rat isolated ileum, contractile responses to EFS were 
decreased by the petals extracts. Contractions of ileum to EFS are mediated by both noradrenaline and ATP 
released as co-transmitters from sympathetic nerves (36). The discrepancy regarding the possible 
mechanisms of the relaxant effect of crocin on smooth muscle observe in the above study and the current 
study may be due to the types of smooth muscles (caprine detrusor muscle vs tracheal) and the distribution 
of various receptor and channels in different types of smooth muscle. 
Although the concentrations of thephylline and crocin were not the same, their concentrations were 
chosen according the previous studies (30, 45). In addition, theophylline was used as a positive control in 
the present study as previous studies. Therefore, the effects of high, medium, and low concentrations of 
crocin were compared to the effect of corresponding concentrations of theophylline.  
In conclusion, the present study has demonstrated a relatively potent relaxant effect of crocin on 
tracheal smooth muscle which was lower compared to the effect of theophylline at studied concentration. 
The ﬁndings also suggested that the possible mechanisms of the relaxant effect of the crocin on tracheal 
smooth muscle including muscarinic receptor blocking, potassium channels opening, and ß2-
adrenoreceptors stimulation. 
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